HERmark Breast Cancer Assay

To educate and generate interest in HERmark^®, a new HER2 assay for metastatic breast cancer, it was important to differentiate the product from previous assays, because it has the ability to assist oncologists in individualizing each patient’s treatment with more dimension and detail than ever before. Our team created a campaign featuring a unique illustration style that conveyed the HERmark difference: a more accurate, more detailed look at HER2 total protein expression and dimerization.